Professor of Medicine, University Fla College of Medicine
Cardiology
Dr. Theodore A. Bass, MD
|
|
Give Review
Theodore A. Bass is an expert in the field of Cardiology. He graduated from Warren Alpert Medical School of Brown University. He received awards:"America's Top Doctors", "Men's Health", "Top Doctors: Florida" and "Fellow (FACC)". Theodore Bass is also published. He has 85 publications published. The lastest publication: "Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Effects of dabigatran on the cellular and protein phase of coagulation in patients with Coronary artery disease on dual antiplatelet therapy with aspirin and clopidogr...
- A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with Coronary artery disease: results of a prospecti...
- Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease.
- Operator Radiation Exposure and Physical Discomfort During a Right Versus Left Radial Approach for Coronary Interventions: A Randomized Evaluation.
- Roadmap to quality and innovation.
- Appropriate use criteria for cardiac catheterization and Coronary revascularization.
- Quality initiatives in the cardiac catheterization and interventional laboratories.
- Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor-Mediated Signaling in Prasugrel-Treated Patients.
- Cigarette Smoking and Antiplatelet Effects of Aspirin Monotherapy Versus Clopidogrel Monotherapy in Patients with Atherosclerotic Disease: Results of a Prospective Pha...
- Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction: Shifting Paradigms and Future Perspectives.
- Impact of Cigarette Smoking on P2Y12 Receptor Binding Activity Before and After Clopidogrel Therapy in Patients with Coronary Artery Disease.
- Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with Coronary artery disease.
- Impact of aspirin dose on adenosine diphosphate-mediated platelet activity. Results of an in vitro pilot investigation.
- Impact of prasugrel reload dosing regimens on high on-treatment platelet reactivity rates in patients on maintenance prasugrel therapy.
- Effects of cangrelor in Coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
- Impact of renal function on clopidogrel-induced antiplatelet effects in Coronary artery disease patients without diabetes mellitus.
- Candidates for transcatheter Aortic valve replacement (TAVR): Fitting the PARTNERS criteria.
- Certification and competency in interventional cardiology: the changing landscape.
- Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.
- Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and Coronary artery disease: results of a pharmacody...
- Percutaneous Coronary intervention versus Coronary artery bypass graft surgery in left main Coronary artery disease a meta-analysis of randomized clinical data.
- Impact of gastric Acid-suppressing therapies on platelet reactivity in patients with Coronary artery disease treated with clopidogrel results of a pharmacodynamic study.
- Response to letter regarding article, "pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with Coronary artery disease".
- Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and Coronary artery disease on dual antiplatelet therapy with aspirin ...
- Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and Coronary artery disease.
- Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel Effects: Results of a Prospective, Randomized, Crossover Study.
- Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with Coronary artery disease.
- Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study.
- Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with Coronary artery disease taking dual antiplatelet therapy.
- Health Care Reform Bill H. R. 3200--America's Affordable Health Choices Act: what is missing?
- Pharmacogenetics in cardiovascular antithrombotic therapy.
- Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
- Acknowledging a failed strategy.
- Strategies for drug-eluting stent treatment of bifurcation Coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
- Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main Coronary artery disease.
- Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
- Long-term outcomes in patients undergoing Coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
- Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous Coronary intervention with drug-eluting stents.
- Managing patients with intermediate in-stent restenotic lesions: is it "prime time" for intravascular ultrasound imaging?
- Clinical profile of prasugrel, a novel thienopyridine.
- Current antiplatelet therapies: benefits and limitations.
- Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients w...
- Aspirin desensitization in patients undergoing percutaneous Coronary interventions with stent implantation.
- Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography.
- Functional effects of high clopidogrel maintenance dosing in patients with inadequate platelet inhibition on standard dose treatment.
- A systematic review of outcomes in patients with staged carotid artery stenting and Coronary artery bypass graft surgery.
- Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabet...
- Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and Coronary artery disease.
- Direct stenting in the DES era: Can we do better?
- Heterogeneity of atherosclerotic plaque characteristics in human Coronary artery disease: a three-dimensional intravascular ultrasound study.
- Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic Coronary artery disease as measured by Coronary angiography and fractional flow rese...
- Evaluation of cardiac magnetic resonance imaging parameters to detect anatomically and hemodynamically significant Coronary artery disease.
- Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
- Quantitative contrast enhanced magnetic resonance imaging for the evaluation of peripheral arterial Disease: a comparative study versus standard digital angiography.
- Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and Coronary artery disease: results of the Optimizing Antiplatelet The...
- Anatomical and physiologic assessments in patients with small Coronary artery disease: final results of the Physiologic and Anatomical Evaluation Prior to and After St...
- Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: incidence and impact on angiographic late loss.
- Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with Coronary artery disease.
- Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
- Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
- Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.
- Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and Coronary artery disease.
- "Menage a trois" or "no mas".
- Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.
- DES: technique still matters.
- Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous Coronary intervention.
- Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary Heart disease and influence of the 807 C/T polymorp...
- Platelet function profiles in patients with type 2 diabetes and Coronary artery disease on combined aspirin and clopidogrel treatment.
- Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing Coronary stenting.
- Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with Coronary artery disease.
- Stenting small vessels? Not a small issue.
- Left main Coronary artery: we are getting closer.
- Overstretching undersized drug-eluting stents: a temporary solution.
- Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft Disease.
- Hemodynamic complications of ventricular septal rupture after Acute myocardial infarction.
- Brachytherapy for in-stent restenosis: the problem is one of commitment.
- Debulking does not benefit patients undergoing intraCoronary beta-radiation therapy for in-stent restenosis: insights from the START trial.
- Does the cutting balloon make the final cut?
- Intravascular ultrasound catheter entrapment after Coronary artery stenting.
- Caught between a rock and a hard place? It is good to have some help.
- Post-PCI cardiac events? The answer is the lumen, or is it in the wall?
- Mechanical thrombectomy to the RESCUE.
- Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
- Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study.
Schools
The Warren Alpert Medical School Of Brown University
Mayo Clinic Rochester
University Hospital Boston
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Men's Health
- Top Doctors: Florida
- Fellow (FACC)
Education
-
Boston University Medical Center -
Mayo School of Graduate Medical Education -
Warren Alpert Medical School of Brown University
Hospital
-
UF Health Jacksonville
Drug Facts
| NPI NUMBER | 1902872740 | |
| NPPES Provider LastName | BASS | |
| NPPES Provider FirstName | THEODORE | |
| NPPES Provider ZIPCode | 322096511 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 189.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902872740 |
| Last Name Of The Provider | BASS |
| First Name Of The Provider | THEODORE |
| View All |
Similar Doctors
|
Dr. Olufunso W. Odunukan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine M. Duello, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sumant Lamba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory C. Tomlinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vasco R. Geer III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manish K. Bansal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Safford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mona J. Shah, MD |
|
Dr. Pankaj H. Gandhi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jesus G. Pulido, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gladys P. Velarde, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Praveen K. Kanaparti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thinn Hlaing, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Waddah Salman, MD
This Doctor is OpenDoctor Recommended.
|